Epii HPT6: Sorry, It Won't Rebuild Your Skin

Can Epii's HPT6 Drop and Cream really firm skin in the "deeper layer," as the box says? A cosmetic chemist's formula analysis and what the evidence says. Free and independent.

Skincare on social media is a lot of noise.

There are enough people talking at you already, sharing and sharing what they love, what is new, the thing you “absolutely HAVE to try.” And part of that is what they are paid to promote. I am not shaming anyone for it. It is expected, it is a job, and I do sponsored work too. As a consumer myself, I am on your side here, because I know how overwhelming it gets, and how hard it is to cut through the marketing and find the products that actually do something for your skin.

That is what I love most about science. It has a very grounding effect.

So today, since so many of you got very excited about the Epii HPT6 range, let’s look at it through that grounding lens.

*A quick note before we start. I’d planned to put this one behind the paywall. But Epii is everywhere on your feeds right now, and I’d rather more of you understood what you’re actually buying than have it sat where fewer people could read it. So it’s free, all of it.*

If you do choose to support my work today, thank you. This is simply the standard of what I do here, and paid subscriptions are what make the deep dives possible. No pressure either way. Read it, share it with whoever’s about to click buy, and take what’s useful.

---

Epii’s promise

Epii’s whole pitch rests on one idea, repeated across every single asset: firmness is not built on the surface, it is built in the “deeper layer,” and that is where HPT6 works.

They even show you the diagram.

Epii’s skin-layer diagram showing HPT working at the DEJ and Matrixyl Synthe’6 in the dermis

The brand’s own mechanism diagram. Look at where the two actives are placed: right at the dermo-epidermal junction, and down in the dermis.

Read the promise carefully, because it is unusually specific for a cosmetic:

HPT “helps synthesis of GAGs (glycosaminoglycans) and key DEJ proteins (Collagen IV, Laminin-5, Nidogen).”

Matrixyl Synthe’6 “helps synthesis of 6 key proteins” at the DEJ and papillary dermis.

“Structural firmness restored at 2 depths.”

And this is a smart target to pick, not a made-up one. The DEJ, the dermo-epidermal junction, is the wavy seam where your epidermis meets your dermis. It is a real, important structure, and it genuinely does flatten with age. That flattening is part of why older skin loses its bounce. So Epii has pointed at something that truly matters.

But look at that diagram again. Everything they are promising happens below the surface. At the junction. In the dermis. Which means the entire range lives or dies on one question:

Can what is in these bottles actually get down to the dermis? And if it can’t, can it at least send a signal that does?

---

Meet the hero

The molecule doing the heavy lifting is called Hydroxypropyl Tetrahydropyrantriol. You may know it better by its L’Oreal trade name, Pro-Xylane.

Pro-Xylane is a small synthetic molecule L’Oreal built from xylose, a plant sugar originally pulled from beech wood. Its best-supported job is to act like a “primer” that encourages your skin to make more glycosaminoglycans, the water-holding sugar chains that keep skin plump, and to support several of the proteins that build the DEJ. So when Epii says HPT “helps synthesis of GAGs and DEJ proteins,” they did not invent that. It is in the literature.

There’s a catch, though. Two, actually.

First, almost all of that literature comes from L’Oreal. The synthesis papers, the GAG work, the DEJ studies, the human data: overwhelmingly authored or funded by the company that developed and sells the molecule. That does not make it wrong. L’Oreal does serious science.

But independent replication, done by people with no skin in the game, is thin. On my evidence scale I would put the mechanism at T3 to T4, mostly manufacturer-funded, with some in-house human work at T2, and no independent trial on these Epii products at all (which, to be fair, is true of nearly every cosmetic brand).

Second, and this is the one that feeds straight back into our question: nobody has published a study actually measuring how much of this molecule gets through intact human skin, or how deep it travels. Its ability to reach the dermis is inferred from the downstream biology. It has never been directly measured.

And that gap is more glaring once you have seen the alternative. When I looked at Medik8’s PDRN serum, the brand had actually run in-vitro penetration work on its active, comparing how its PDRN crossed skin against rose and salmon sources. You can argue about what lab penetration data really proves, and I did in that piece. But at least the question was asked and measured. With Pro-Xylane here, it simply has not been.

---

The physics problem nobody puts on the box

For a molecule smoothed onto your face to reach the DEJ, it has to cross your stratum corneum, the outermost layer of your skin. And your stratum corneum is, essentially, a brick wall built to keep things out. Bricks of dead cells, mortar made of lipids, fats. It is one of the most effective barriers in nature. It has to be. It is the thing standing between you and the world.

Chemists use a rough rule of thumb here: molecules over about 500 Daltons (a unit of molecular size) struggle to get through passively, and molecules that love water more than oil struggle too, because that lipid mortar is oily and repels them.

Now hold the two Epii actives up against that wall.

Pro-Xylane is small. Around 190 Daltons, comfortably under the limit. First hurdle cleared. But it is also extremely water-loving. It is a little sugar-derived molecule covered in water-friendly groups. So it clears the size test and then walks straight into the solubility problem. Small gets you to the wall. Being this hydrophilic means the oily mortar does not want to let you through. Size and solubility pull in opposite directions, and that tension is never resolved by anything on the label.

Now the peptide. Matrixyl Synthe’6’s active peptide is large, around 676 Daltons, over the 500 Dalton guideline, so on size alone it would struggle to cross on its own. That is exactly why it comes with a lift. The palmitoyl tail bolted onto it is a fatty anchor that helps it slip into the skin’s lipids, which is the standard, sensible way this class of peptide is built for absorption.

Matrikines like this are potent at tiny concentrations, and that is a feature, not a flaw. Low ppm is not the weakness people assume it is. A well-delivered peptide at a few ppm is a genuine active. And the mechanism is real: in cell studies, Synthe’6 does switch on collagen, fibronectin, hyaluronic acid and laminin, with sizeable numbers.

This is the kind of thing I always check, because it changes how much weight a number can carry: as of early 2026, every published performance study on this particular peptide comes from Sederma, the company that makes it. No independent lab has published a trial on it yet. That does not make it fake. The mechanism is sound and the peptide class is well established. It just means the impressive figures are the maker’s own, and the sensible expectation is a real but modest effect built over months, not the structural rebuild the box implies.

So here is where the range’s central promise actually stands. The claim is that both actives work at the DEJ and in the dermis. For Pro-Xylane, the chemistry is fighting its own water-loving nature to get there. For the peptide, the mechanism is real and the palmitoyl tail genuinely helps, but how much reaches living fibroblasts from any given formula is the open question, and here, crucially, there is no published measurement showing either one arrives at the depth the claims need. Not from L’Oreal, not from Sederma, not from anyone.

---

So can it signal its way down instead?

If I were writing Epii’s copy, this is where I’d steer. An active doesn’t have to reach the dermis to affect it.

And that is true. The epidermis and the dermis are not sealed off from each other. They talk. Living cells in the epidermis, keratinocytes, are chemically chatty, and when you stimulate them they release messengers that can drift downward and influence the fibroblasts below. Skin biologists call this paracrine signalling, cell-to-cell crosstalk. So in principle, an active that only reaches the living epidermis could send a signal deeper than it physically travels. This is real biology, and it is genuinely the most honest reading of what Pro-Xylane might do: reach the basal keratinocytes, nudge them, and let some of that message carry down.

Here is why it still does not rescue the claim on the box. A paracrine whisper is a message, not a construction crew. Even granting the entire cascade, a faint signal reaching fibroblasts is a world away from “real firmness restored in the deeper layer.” Meaningful collagen or matrix change is slow, dose-dependent, and hard to achieve even with actives we know reach fibroblasts directly.

And here is where the science grounds it. A faint signal from a modest dose up in the epidermis will not rebuild your DEJ. The mechanism is plausible. The word doing all the damage is “restored.”

---

Does the base at least get them to the epidermis? Sort of, barely

The base helps a little. Not nothing, not a lot.

The real tool in both formulas is the glycol complex: propanediol, dipropylene glycol, butylene glycol, 1,2-hexanediol. These genuinely do assist penetration, partly by keeping a water-loving active dissolved and “pushing” to leave the formula, partly by mildly loosening and hydrating that brick-and-mortar barrier. Propanediol in particular has some published support here. But glycols are a gentle push, not a key. They do not unlock the barrier. They take a molecule that struggles across and let a bit more of it through, and a bit more of very little is still not much.

If you’re into cosmetic chemistry, or you’ve followed me for a while, you’ll know Hydroxypropyl Cyclodextrin, which is in this formula too. Here it has an obvious reason to be present: it is one of the ingredients the Matrixyl Synthe’6 raw material is supplied in, alongside glycerin and water. Its job in that blend is keeping the awkward, lipidated peptide dissolved and stable, which it does well.

But solubilising a peptide in the bottle is not the same as carrying it deep into skin. Cyclodextrins work by caging a guest molecule, and the penetration data is a double-edged thing: a little cyclodextrin helps by keeping the active dissolved, but too much holds the active in the vehicle and can actually reduce how much crosses the skin. In some formulations that is used on purpose, to stop an ingredient penetrating too deeply. So it is a solubiliser and a stabiliser, genuinely useful ones, but I would not count it as a penetration win for either active.

This is what settles it for me. If depth were the goal, this is not how you would build the base. You would reach for real delivery technology: liposomes, encapsulation engineered for the dermis, deliberate ion-pairing, the formats that exist for exactly this problem. That kind of engineering costs more. It would also work better. This product is priced to be accessible, and that is a reasonable choice, it just means you should not expect luxury-tier delivery from it.

Here is the most plausible reality of these products: some Pro-Xylane reaches the viable epidermis. Enough that the keratinocyte-signalling story holds up as a real possibility, not fiction. But “enough to whisper” and “enough to firm and rebuild” are separated by orders of magnitude, and nothing in this base actually bridges that gap.

So things do happen. They just happen higher up, at the surface and in the upper epidermis, which is where topicals work and where most of what you see and feel comes from anyway. It is real. It is just not the marketing story.

---

“10%” is not what you think it is

Since I’m pulling back the curtain a bit today, let’s talk about the gap between a declared concentration and how much active is actually in there. It matters for everything, and for peptides most of all.

The pack says “HPT 10% + Matrixyl Synthe’6 2%.” Your brain reads that as ten percent of the hero molecule, which sounds potent. It almost certainly is not that.

Pro-Xylane is sold to formulators as a solution, commonly around 30% active in water and glycol. And L’Oreal’s own published work uses the pure molecule at roughly 1 to 3%. So a formula built around 10% of the supplied blend lands you in exactly that sensible 2-to-3% pure-active zone. Which is good. It is a respectable, literature-appropriate dose. It is just not “10% of the hero,” which is the picture the label invites.

The “2%” peptide figure works the same way. That refers to the trade blend, and the blend is heavily diluted, so the actual peptide is present at parts-per-million levels. Completely normal. That is how these peptides are used and tested. But “2%” reads a lot bigger than the working dose really is.

None of this is a scandal. It is standard industry shorthand. I am just walking you around to the front of the mirror so you buy the real thing, not the inflated mental picture of it.

And quickly, because a few of you asked: the range comes in a 5% and a 10% of both the Drop and the Cream. So if you spotted a “5%” somewhere and a “10%” elsewhere, that is not a mislabel, just the two siblings in the line. The 10% is the stronger “Forte” version.

The full line. Two strengths each. The “5% vs 10%” is just the siblings.

---

Now the part the marketing undersells, per usual ( deep sigh..)

If the deep-firming story is the weak part of these products, the supporting cast is the strong part, and it is the reason I would actually reach for one of them.

Both formulas are built on a properly nice group of hydrating, soothing and antioxidant ingredients. Glycerin, sodium hyaluronate, panthenol, allantoin, ectoin. That is a reliable, well-evidenced backbone for comments like “my skin looks plumper and smoother and feels more comfortable within a couple of weeks.”

And yes, this genuinely happens. This is the high-tier, boring, dependable evidence, the stuff I’d stake my name on. Ectoin in particular has independent human data for hydration and barrier support. There is also a low dose of adenosine, an ingredient with decent evidence for softening fine lines, approved as an anti-wrinkle active in Korea at 0.04%. A quiet, plausible contributor.

Ergothioneine is a good antioxidant, lovely to see on a list, though almost certainly present below the levels where its independent evidence was generated, so I read it as supportive rather than headline.

Carnosine is more interesting than the antioxidant label suggests. It is an anti-glycation agent, which means it helps stop sugars from binding to and stiffening your collagen, one of the quieter drivers of skin ageing. There is even ex-vivo human skin data showing topical carnosine lowers glycation markers. The problem is dose: the anti-glycation work points to something in the low single-digit percentages, and here carnosine sits low on the list, so it is likely a supporting note rather than a therapeutic level.

But the ingredient I actually want to talk about is in the cream, and it has nothing to do with HPT6 at all.

The cream contains a real *barrier-repair lipid system: ceramides, cholesterol and free fatty acids, plus squalane. This is not marketing. Your skin barrier is literally built from those three families of lipid, and topping them up genuinely helps a stressed barrier hold water and calm down. There is a solid, independent dermatology literature behind this approach (the classic Elias and Man barrier work). This is T1 to T2 evidence, and it acts precisely where a cream can act. No penetration mystery, no inference, no leap of faith. It just works.

Epii brands it as a “3:1:1” ratio. The research behind that ratio is looser than the tidy number suggests. What actually matters is having all three lipids there in decent amounts. The original studies found that even equal parts of all three (1:1:1) repairs the barrier normally, and that bumping up any one of them can speed repair a little. So a ceramide-heavy 3:1:1 is a sensible choice, not a strict requirement. Worth knowing too that in older skin specifically, the research points to cholesterol being the lipid best made dominant, not ceramide. So I would not treat the exact “3:1:1” as the gospel. The win is simply that all three lipids are there, in a rich base, doing honest work.

This is why, if you are choosing between them, I lean toward the cream. Not because it delivers HPT6 to your dermis any better (it does not), but because it has a second, completely separate, genuinely evidence-based benefit the serum lacks. The serum is a pleasant hydrating layer. The cream is a pleasant hydrating layer and a legitimate barrier cream.

”Barrier shield” is the claim I would happily stand behind. “Structural firmness” is the one I would not.

---

Three small things, because you know I can’t help myself

Melatonin in frosted glass. Melatonin degrades in light, and both products come in gorgeous frosted, translucent packaging. Beautiful on a shelf, less kind to the melatonin over time. But the packaging was clearly chosen to photograph well, not to protect a light-sensitive ingredient. Or perhaps they knew the melatonin is barely doing anything here anyway, just saying...

”Niacinamide-free” as a selling point. Stated as fact, fine. But niacinamide is one of the best-evidenced, most useful actives in all of skincare, and framing “free from a genuinely good ingredient” as a virtue is a marketing move, not a benefit. No fear needed in either direction. It is simply left out.

The Dermatest “Excellent” seal. That blue badge certifies skin compatibility and tolerance: broadly, that it did not irritate people in testing. That is a real and useful thing to know, and it is a good sign the product is gentle. It is not a test of whether the firming or DEJ claims are true. Two completely different badges. It is easy to read “Excellent” as “proven to work,” when it actually means “proven to be well tolerated.”

The whole thing, on one screen

---

So, should you buy it?

Yes, I’d say give these a try. The price is good, and if you’re on a budget, these formulas are built more interestingly than a lot of what’s in this category. Just keep your expectations realistic.

Reach for the cream if you want a comfortable, genuinely barrier-supporting moisturiser with a lovely hydrating, soothing supporting cast, and you like the idea of Pro-Xylane along for the ride rather than as a headline act. On that basis it is a good product. The barrier lipids alone earn it a place. Your skin will likely look plumper and calmer and feel more resilient, and that is real.

Reach for the serum if you specifically want a lighter layer and you are already sorted for barrier lipids elsewhere. It is a nice hydrating serum with the same heroes. It just does not have the cream’s stronger second string.

Do not buy either one expecting measurable firmness from your dermis, a rebuilt DEJ, or “structural” change at “2 depths.” No topical does that. Not this one, not the expensive ones, not the ones with bigger ad budgets. If real dermal remodelling is the goal, that conversation is about retinoids, sun protection (the single highest-value anti-ageing step there is), and in-clinic procedures. A cream is a cream.

The Epii range is a competent, pleasant, well-built pair of hydration-and-barrier products with a real, researched hero active dosed at a sensible level. The cream, in particular, is a solid barrier cream. What I cannot agree with is the story. “Deeper layer, structural firmness at 2 depths” takes a molecule with modest, mostly in-house evidence and no demonstrated delivery to the dermis, and sells it as architecture for your face. The ingredients are better than the average launch. The promises per usual are more stretched than the ingredients can keep.

That’s the grounded, chemist-vetted verdict. M xx

Disclaimer: I have no partnership with Epii and received no product, payment, or brief from them. This is an independent read based on the published INCI lists, the brand’s own promotional claims, and the peer-reviewed literature on the ingredients. Where the evidence is manufacturer-generated, I have said so. Where it does not exist yet, I have said that too. This free, independent work is the whole point of what I do here.